Use of avacopan in severe forms of ANCA-associated vasculitis. Comment on “Inhibiting C5a/C5aR to treat ANCA-associated vasculitides” by Terrier et al. Joint Bone Spine 2023;90:105472
| Autor: | Astouati, Quentin, Provot, François, Farhat, Meryem-Maud, Launay, David, Sanges, Sébastien |
|---|---|
| Zdroj: | In Joint Bone Spine March 2023 90(2) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect